(Q74150197)

English

Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinica

scientific article published on 01 January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

author name string

H J Coelingh Bennink

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B C Fauser

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H J Out

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

19-25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon).

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900423-8

7 January 2021

Identifiers

10.1016/S0015-0282(97)00423-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457926%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74150197&oldid=1756701202"